Descrizione del progetto
Navigazione dei tessuti molli: ingegneri biomedici e medici in fase iniziale di carriera sviluppano nuove soluzioni
La navigazione dei tessuti molli durante gli interventi chirurgici, in particolare la resezione chirurgica dei tumori, è resa complicata dalle difficoltà di ottenere la precisione desiderata in organi deformabili che si muovono in risposta alla respirazione, al battito cardiaco e all’intervento stesso. Molti pazienti con carcinoma epatocellulare, il principale tipo di tumore primario del fegato, non possono essere sottoposti a resezione, mentre la prognosi di altri è influenzata dalle difficoltà insite nella navigazione dei tessuti molli. Grazie al sostegno del programma azioni Marie Skłodowska-Curie, il progetto HiPerNav formerà ricercatori in fase iniziale di carriera in materia di trattamenti minimamente invasivi, ingegneria biomedica, metodologie di ricerca e imprenditorialità. La ricerca colmerà il divario tra le idee teoriche e la pratica clinica testando prototipi e sviluppando soluzioni e strumenti reali.
Obiettivo
Primary liver cancer, which consists predominantly of hepatocellular carcinoma (HCC), is the fifth most common cancer worldwide and the third most common cause of cancer mortality. A successful surgical resection of HCC requires complete removal of the tumour while sparing as much healthy tissue as possible. Due to technical and clinical difficulties relatively low percentage of patients are eligible for resection. There is an urgent need to increase the patient eligibility and improve the survival prognosis after liver interventions. HiPerNav will train early stage researchers (biomedical engineers and medical doctors) to become international leading in key areas of expertise through a novel coordinated plan of individual research projects addressing specific bottlenecks in soft tissue navigation for improved treatment of liver cancer. The multi-disciplinary dialogue and work between clinicians and biomedical engineers is crucial to address these bottlenecks. By providing researchers with knowledge and training within specific topics from minimally invasive treatment, biomedical engineering, research methodologies, innovation and entrepreneurship, the link between academic research and industry will be strengthened. This allows for easy transfer of promising results from the research projects to commercially exploitable solutions. The global image guided surgery devices market is promising; it was valued at USD 2.76 billion in 2013 and is projected to expand 6.4% from 2014 to 2022 to reach USD 4.80 billion in 2022. The market for soft-tissue navigation is still in its infancy, mainly due to challenges in achieved accuracy for targeting deformable and moving organs. By providing multi-disciplinary training, the researchers in this consortium of international leading research institutions, universities and industry will initiate true translational research from academic theoretical ideas to the clinical testing of prototype, developed solutions and tools.
Campo scientifico
- medical and health sciencesmedical biotechnology
- medical and health sciencesclinical medicineoncologyliver cancer
- medical and health sciencesbasic medicineanatomy and morphology
- medical and health sciencesclinical medicinesurgerysurgical specialties
- medical and health sciencesclinical medicineoncologypancreatic cancer
Programma(i)
Argomento(i)
Meccanismo di finanziamento
MSCA-ITN-ETN - European Training NetworksCoordinatore
0450 Oslo
Norvegia